Lenacapavir
Stories
-
Gilead posts results of ARTISTRY-1 bictegravir/lenacapavir study
The study, enrolling 689 participants, compared bictegravir/lenacapavir to stable baseline regimens in virologically suppressed people with HIV-1. Results were first posted on ClinicalTrials.gov on October 21, 2026.